VERSACLOZ.COM: Keyword Density Checker

Total words: 4333 | 2-word phrases: 1136 | 3-word phrases: 1280 | 4-word phrases: 1332

PAGE INFO

Title	Try to keep the title under 60 characters (68 characters) Versacloz® (clozapine, USP) Information for Healthcare Providers
Description	Try to keep the meta description between 50 - 160 characters (148 characters) Information for healthcare providers about Versacloz® (clozapine, USP) View Safety Info and full Prescribing Information, including BOXED Warnings.
Keywords	Meta keywords are not recommended anymore (0 characters)
H1	H1 tag on the page (78 characters) After schizophrenia treatment failures,change course—consider Versacloz1

ONE WORD PHRASES 585 Words

#	Keyword	Frequency	Density
1	and	50	8.55%
2	with	44	7.52%
3	of	32	5.47%
4	the	32	5.47%
5	in	28	4.79%
6	patients	27	4.62%
7	or	26	4.44%
8	versacloz	24	4.10%
9	clozapine	21	3.59%
10	for	21	3.59%

TWO WORD PHRASES 1136 Words

#	Keyword	Frequency	Density
1	patients with	12	1.06%
2	is a	10	0.88%
3	in patients	9	0.79%
4	adverse reactions	7	0.62%
5	with a	7	0.62%
6	severe neutropenia	6	0.53%
7	with clozapine	6	0.53%
8	of the	5	0.44%
9	versacloz is	5	0.44%
10	have occurred	5	0.44%
11	dementiarelated psychosis	5	0.44%
12	the risk	5	0.44%
13	with dementiarelated	4	0.35%
14	treated with	4	0.35%
15	in a	4	0.35%
16	pharma inc	4	0.35%
17	tasman pharma	4	0.35%
18	clozapine rems	4	0.35%
19	treatment with	4	0.35%
20	including clozapine	4	0.35%

THREE WORD PHRASES 1280 Words

#	Keyword	Frequency	Density
1	in patients with	4	0.31%
2	with dementiarelated psychosis	4	0.31%
3	tasman pharma inc	4	0.31%
4	antipsychotics including clozapine	3	0.23%
5	risk factors for	3	0.23%
6	clozapine rems program	3	0.23%
7	the clozapine rems	3	0.23%
8	occurred with clozapine	3	0.23%
9	have occurred with	3	0.23%
10	patients with dementiarelated	3	0.23%
11	can lead to	2	0.16%
12	treated with antipsychotic	2	0.16%
13	full prescribing information	2	0.16%
14	pa tasman pharma	2	0.16%
15	mortality in elderly	2	0.16%
16	a history of	2	0.16%
17	with a history	2	0.16%
18	must be at	2	0.16%
19	be at least	2	0.16%
20	because of the	2	0.16%
21	versacloz is a	2	0.16%
22	the effectiveness of	2	0.16%
23	with antipsychotic drugs	2	0.16%
24	in patients who	2	0.16%
25	severe neutropenia or	2	0.16%
26	increased mortality in	2	0.16%
27	effectiveness of clozapine	2	0.16%
28	of clozapine was	2	0.16%
29	has been reported	2	0.16%
30	patients treated with	2	0.16%

FOUR WORD PHRASES 1332 Words

#	Keyword	Frequency	Density
1	have occurred with clozapine	3	0.23%
2	patients with dementiarelated psychosis	3	0.23%
3	increased mortality in elderly	2	0.15%
4	must be at least	2	0.15%
5	treated with antipsychotic drugs	2	0.15%
6	with a history of	2	0.15%
7	pa tasman pharma inc	2	0.15%
8	the effectiveness of clozapine	2	0.15%
9	the clozapine rems program	2	0.15%
10	occurred with clozapine treatment	2	0.15%
11	effectiveness of clozapine was	2	0.15%
12	treatment the risk is	2	0.15%
13	patients treated with atypical	2	0.15%
14	is a registered trademark	2	0.15%
15	a registered trademark of	2	0.15%
16	discontinuation is necessary monitor	1	0.08%
17	versacloz with caution in	1	0.08%
18	patients with risk factors	1	0.08%
19	with risk factors for	1	0.08%
20	risk factors for cerebrovascular	1	0.08%
21	reactions ≥5 were cns	1	0.08%
22	factors for cerebrovascular adverse	1	0.08%
23	for cerebrovascular adverse reactions	1	0.08%
24	cerebrovascular adverse reactions if	1	0.08%
25	adverse reactions ≥5 were	1	0.08%
26	abrupt discontinuation is necessary	1	0.08%
27	is necessary monitor carefully	1	0.08%
28	cholinergic rebound most common	1	0.08%
29	necessary monitor carefully for	1	0.08%
30	monitor carefully for the	1	0.08%
31	recurrence of psychotic symptoms	1	0.08%
32	of psychotic symptoms and	1	0.08%
33	common adverse reactions ≥5	1	0.08%
34	antipsychotics use versacloz with	1	0.08%
35	psychotic symptoms and adverse	1	0.08%
36	symptoms and adverse reactions	1	0.08%
37	and adverse reactions related	1	0.08%
38	adverse reactions related to	1	0.08%
39	most common adverse reactions	1	0.08%
40	rebound most common adverse	1	0.08%